ADSCC BONE MARROW TRANSPLANT & CELLULAR THERAPY CONGRESS 2024

October 26-27, 2024
Rixos Marina Abu Dhabi, UAE

ADVANCING HEALTHCARE TODAY FOR TOMORROW

The ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2024 is on a mission to spearhead efforts that foster an open platform for exploring the cutting-edge advancements and breakthroughs in bone marrow transplant, cellular therapy, and regenerative medicine. The goal is to cultivate a space that promotes learning, sharing, and discovery in these fields. Together, we can shape the future of healthcare, transcending boundaries and making a profound impact on the lives of patients worldwide.

The highly anticipated ADSCC Bone Marrow Transplant & Cellular Therapy Congress is scheduled for 26-27 October at Rixos Marina Abu Dhabi, United Arab Emirates.

30+

Sessions

37+

Intenational Speakers

600+

Delegates

Scientific Committee

Dr Fatima Al Kaabi

Congress President, ADSCC

Dr Inas El-Najjar

Scientific Committee Chair

Dr Nameer Al-Saadawi

Scientific Committee Co-Chair

Dr David Dennison

Consultant, Hematology and Bone Marrow Transplant, ADSCC

Dr Mohammed Abu Haleeqa

Consultant, Hematology & Bone Marrow Transplant / Chair of Academic Affairs, ADSCC

Dr Mansi Sachdev

Clinical Lead & Consultant, Pediatric Hematology, Oncology & BMT, ADSCC

Dr Yandy Aleman

Specialist, Immunology & Head of Clinical Trials, ADSCC

Dr Leslie Lehmann

Director, Clinical Stem Cell Transplantation Program; Medical Director, International Hematology/Oncology/BMT Associate Professor, Harvard Medical School

Dr Rupert Handgretinger

Dr Angelo Visconi

Professor of Cell Biology

Dr Gisela Formigo

Research and Development Project Manager

Dr Raafat Abu Alnoor

Indiana University Health

Dr Panagiotis Kottaridis

UCLH

Dina El Mouzain

Director of Nursing, ADSCC

TOPICS

CAR T Treatment Updates
New Perspectives in Cancer Imunotherapy
Challenges in Myeliod Malignancies
Changing the paradigm in Multiple Sclerosis Treatment
Next Generation Therapies for the Future
Immune R econstitution pots BMT
IPS Related Talks
Myeloma/ Lymphoma Session
Gene Therapy in Aemoglobinopathies
Lymphoma, Meyloma and Amyloid
What is New in GVHD Management
Focus on BMT Complications
Nursing

We are proud to feature over 37 distinguished international speakers from across the globe. These leading experts, hailing from top research institutions and clinical centers, will bring a wealth of knowledge and diverse viewpoints to the event. Their presentations will cover the latest advancements and emerging trends in bone marrow transplant and cellular therapy, ensuring a rich and engaging experience for all attendees.